Health Care Equipment & Services

Boston Scientific’s recent SEC filings reveal a focus on governance and a possible business combination, hinting at strategic growth in the medical device market.

Explore how CVS Health’s $5.2 billion Oak Street acquisition and PBM lawsuit impact its debt, margins, and share price volatility—key insights for investors.

UHS shows steady earnings growth, strategic tech adoption, and analyst “buy” ratings, making it a compelling choice for investors eyeing resilient healthcare management stocks.

EssilorLuxottica faces U.S. class‑action suits over disputed tariffs, with implications for pricing, supply chains and patient costs. Learn how the legal battle could reshape eyewear affordability and industry practices.

Investors eye Siemens Healthineers: AI‑driven imaging, strong buybacks, ethical supply‑chain risks, and a spin‑off reshape the future of medical tech.

Fresenius SE & Co KGaA’s Q3 2026 earnings hit mixed but steady growth from Kabi and Helios, while cost‑saving plans and AI‑driven diagnostics position the group to weather EU reimbursement reforms and boost shareholder value.

UnitedHealth raises its dividend to $2.21, launches a $4 billion buy‑back and cuts debt to a 2.5x leverage goal—boosting shareholder value while tightening costs.

Fresenius Medical Care AG tops Q4 2025 forecasts, boosting EBITDA & revenue while navigating U.S. Medicare caps and EU RDI pressures – a promising recovery with tele‑dialysis and AI opportunities.

Labcorp’s steady growth, strong margins, and AI‑driven expansion into tele‑lab, at‑home testing and genomic services position the diagnostics leader to capture rising reimbursement opportunities while boosting patient access and cost efficiency.

Discover how Steris Public Limited Company’s infection‑control solutions power global hospital growth, driving innovation and investor confidence.